MIR600HG and neoplasm: MIR600HG was observed to inhibit stemness, metastasis and oxaliplatin resistance in CRC by targeting ALDH1A3, and overexpression of MIR600HG combined with oxaliplatin treatment was found to inhibit tumor recurrence.